Skip NavigationSkip to Content
Return Return to Search Results

Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells

  1. Author:
    Wang, L.
    Balasubramanian, P.
    Chen, A. P.
    Kummar, S.
    Evrard, Y. A.
    Kinders, R. J.

  2. Author Address

    Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD. Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD. Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD. Electronic address: kindersr@mail.nih.gov.
    1. Year: 2016
    2. Date: Aug
    3. Epub Date: 9/25/2016
  2. Journal: Seminars in Oncology
    1. 43
    2. 4
    3. Pages: 464-75
  4. Type of Article: Article
  5. ISSN: 0093-7754 (Print) 0093-7754
  1. Abstract:

    Circulating tumor cells (CTCs), which are captured from blood with anti-epithelial cell adhesion molecule (EpCAM) antibodies, have established prognostic value in specific epithelial cancers, but less is known about their utility for assessing patient response to molecularly targeted agents via measurement of pharmacodynamic (PD) endpoints. We discuss the use of CellSearch (Janssen Diagnostics, LLC, Raritan, NJ) CTC isolation technology for monitoring PD response in early phase trials. We present representative data from three clinical trials with the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) suggesting that CTCs can be used to measure PD effects. However, while often leading to hypothesis-generating information, our experience points to the difficulty in obtaining sufficient EpCAM-expressing CTCs from patients with advanced disease to reach statistically significant conclusions about PD effects from each trial. Overall, the level of phenotypic heterogeneity observed in specimens from patients with advanced carcinomas suggests caution in the use of cell-surface differentiation marker-based methods for isolating CTCs.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1053/j.seminoncol.2016.06.004
  3. PMID: 27663478
  4. PMCID: PMC5074690
  5. NIHMSID: NIHMS804642

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel